{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:54:42Z","timestamp":1793836482326,"version":"4.6.1"},"reference-count":100,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1749,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1398-9995.2010.02496.x","type":"journal-article","created":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T07:49:53Z","timestamp":1289980193000},"page":"317-330","source":"Crossref","is-referenced-by-count":675,"title":["Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1"],"prefix":"10.1111","volume":"66","author":[{"given":"M.","family":"Maurer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bindslev-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gim\u00e9nez-Arnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Bousquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bousquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. W.","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. V.","family":"Godse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E. H.","family":"Grattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. W.","family":"Greaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kalogeromitros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. J.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Zuberbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,17]]},"reference":[{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1398-9995.2009.02179.x","article-title":"EAACI\/GA(2)LEN\/EDF\/WAO guideline: definition, classification and diagnosis of urticaria","volume":"64","author":"Zuberbier","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/j.1398-9995.2009.02177.x","article-title":"The definition and diagnostic testing of physical and cholinergic urticarias - EAACI\/GA2LEN\/EDF\/UNEV consensus panel recommendations","volume":"64","author":"Magerl","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/00007611-194108000-00014","article-title":"The atopic factor in urticaria","volume":"34","author":"Swinny","year":"1941","journal-title":"South Med J"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0021-8707(54)90034-9","article-title":"The vexing urticaria problem: present concepts of etiology and management","volume":"25","author":"Sheldon","year":"1954","journal-title":"J Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB5|cit5","first-page":"214","article-title":"Epidemiology of urticaria in Spain","volume":"14","author":"Gaig","year":"2004","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1398-9995.1990.tb00527.x","article-title":"Hay fever, eczema and urticaria in southwest Norway Lifetime prevalences and association with sex, age, smoking habits, occupational airborne exposures and respiratory symptoms","volume":"45","author":"Bakke","year":"1990","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB7|cit7","first-page":"100","article-title":"H\u00e4ufigkeit allergischer Krankheiten in Ost- und Westdeutschland","volume":"61","author":"Herrmann-Kunz","year":"1999","journal-title":"Gesundheitswesen"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB8|cit8","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2230.2010.03840.x","article-title":"Epidemiology of urticaria: a representative cross-sectional population survey","author":"Zuberbier","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1398-9995.1972.tb01420.x","article-title":"The prevalence of urticaria in the total population","volume":"27","author":"Hellgren","year":"1972","journal-title":"Acta Allergol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2133.2002.04582.x","article-title":"The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre","volume":"146","author":"van der Valk","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1067\/mjd.2001.116217","article-title":"Natural course of physical and chronic urticaria and angioedema in 220 patients","volume":"45","author":"Kozel","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1346-8138.2007.00276.x","article-title":"Chronic idiopathic urticaria: prevalence and clinical course","volume":"34","author":"Kulthanan","year":"2007","journal-title":"J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2133.1998.02175.x","article-title":"The characteristics of urticaria in 390 patients","volume":"138","author":"Humphreys","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-4362.1991.tb03891.x","article-title":"Chronic urticaria. Evaluation of the role of physical, immunologic, and other contributory factors","volume":"30","author":"Sibbald","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2222.1982.tb01631.x","article-title":"Chronic urticaria and angioedema","volume":"12","author":"Small","year":"1982","journal-title":"Clin Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB16|cit16","first-page":"421","article-title":"The natural history and response to therapy of chronic urticaria and angioedema","volume":"62","author":"Quaranta","year":"1989","journal-title":"Ann Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2133.1981.tb15306.x","article-title":"Recurrent urticaria: clinical investigation of 330 patients","volume":"104","author":"Juhlin","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1398-9995.2004.00473.x","article-title":"Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients","volume":"59","author":"Toubi","year":"2004","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2133.1969.tb16041.x","article-title":"Urticaria and angio-oedema. A review of 554 patients","volume":"81","author":"Champion","year":"1969","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB20|cit20","first-page":"659","article-title":"Urticaria and angioedema - statistical survey of five hundred cases","volume":"12","author":"Steinhardt","year":"1954","journal-title":"Ann Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0190-9622(99)70495-0","article-title":"Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies","volume":"40","author":"Sabroe","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.0307-6938.2001.00962.x","article-title":"Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria","volume":"27","author":"Nettis","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/00015550410026939","article-title":"Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects","volume":"84","author":"Caproni","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0001-7310(04)76883-0","article-title":"Urticaria cr\u00f3nica: studio etiol\u00f3gico prospectivo e importancia del s\u00edndrome autoinmune","volume":"95","author":"Gim\u00e9nez Arnau","year":"2004","journal-title":"Actas Dermosifiliogr"},{"issue":"Suppl. 2","key":"10.1111\/j.1398-9995.2010.02496.x-BIB25|cit25","first-page":"21","article-title":"Epidemiology, healthcare, resources, use and clinical features of different types of urticaria","volume":"2","author":"Ferrer","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1398-9995.2008.01920.x","article-title":"The German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findings","volume":"64","author":"M\u0142ynek","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB27|cit27","first-page":"134","article-title":"Analysis of the prevalence of subtypes of urticaria and angioedema","volume":"55","author":"Tanaka","year":"2006","journal-title":"Arerugi"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaci.2008.11.040","article-title":"Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria","volume":"123","author":"Metz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1398-9995.2009.02132.x","article-title":"EAACI\/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria","volume":"64","author":"Konstantinou","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000090656","article-title":"Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial","volume":"212","author":"Staubach","year":"2006","journal-title":"Dermatology"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/sj.jid.5700104","article-title":"Neuroimmunology of stress: skin takes center stage","volume":"126","author":"Arck","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2133.1994.tb02900.x","article-title":"The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions","volume":"130","author":"Al\u2019Abadie","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.comppsych.2009.02.005","article-title":"The relationship between posttraumatic stress disorder, psychiatric comorbidity, and personality traits among patients with chronic idiopathic urticaria","volume":"51","author":"Chung","year":"2010","journal-title":"Compr Psychiatry"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/08870440802530780","article-title":"Stress, psychiatric co-morbidity and coping in patients with chronic idiopathic urticaria","volume":"25","author":"Chung","year":"2010","journal-title":"Psychol Health"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.2044-8341.1980.tb02551.x","article-title":"Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections","volume":"53","author":"Fava","year":"1980","journal-title":"Br J Med Psychol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4103\/0378-6323.45100","article-title":"Role of stressful life events in induction or exacerbation of psoriasis and chronic urticaria","volume":"74","author":"Malhotra","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB37|cit37","first-page":"254","article-title":"Stress, insomnia, and chronic idiopathic urticaria - a case-control study","volume":"104","author":"Yang","year":"2005","journal-title":"J Formos Med Assoc"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archderm.123.7.913","article-title":"Effects of relaxation therapy and hypnotizability in chronic urticaria","volume":"123","author":"Shertzer","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0033-3182(73)71307-4","article-title":"Treatment of urticaria and severe headache by behavior therapy. A case study","volume":"14","author":"Daniels","year":"1973","journal-title":"Psychosomatics"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1398-9995.2009.02263.x","article-title":"Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper","volume":"65","author":"Baiardini","year":"2010","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1398-9995.2009.02178.x","article-title":"EAACI\/GA(2)LEN\/EDF\/WAO guideline: management of urticaria","volume":"64","author":"Zuberbier","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2133.1997.tb14895.x","article-title":"The impact of chronic urticaria on the quality of life","volume":"136","author":"O\u2019Donnell","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1034\/j.1398-9995.2003.00091.x","article-title":"Quality of life and patients\u2019 satisfaction in chronic urticaria and respiratory allergy","volume":"58","author":"Baiardini","year":"2003","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2133.2005.06385.x","article-title":"Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life","volume":"152","author":"Grob","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2133.2005.06976.x","article-title":"Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity","volume":"154","author":"Staubach","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1398-9995.2008.01853.x","article-title":"Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation","volume":"64","author":"Maurer","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","article-title":"10\u2003years experience of the Dermatology Life Quality Index (DLQI)","volume":"9","author":"Lewis","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1398-9995.2005.00833.x","article-title":"A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL)","volume":"60","author":"Baiardini","year":"2005","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2133.2002.04758.x","article-title":"Clinical characteristics of pruritus in chronic idiopathic urticaria","volume":"147","author":"Yosipovitch","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2008.08920.x","article-title":"Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients","volume":"160","author":"Maurer","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1098-3597(03)90031-7","article-title":"Insomnia: epidemiology, characteristics, and consequences","volume":"5","author":"Roth","year":"2003","journal-title":"Clin Cornerstone"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00006842-199401000-00005","article-title":"Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria","volume":"56","author":"Gupta","year":"1994","journal-title":"Psychosom Med"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1365-2133.2000.03831.x","article-title":"Psychiatric morbidity in dermatological outpatients: an issue to be recognized","volume":"143","author":"Picardi","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jpsychores.2007.08.006","article-title":"Axis I and Axis II diagnoses in patients with chronic idiopathic urticaria","volume":"64","author":"Uguz","year":"2008","journal-title":"J Psychosom Res"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1468-3083.2007.02324.x","article-title":"The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria","volume":"22","author":"Engin","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.genhosppsych.2008.06.006","article-title":"Quality of life in patients with chronic idiopathic urticaria: the impact of Axis I and Axis II psychiatric disorders","volume":"30","author":"Uguz","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archdermatol.2007.5","article-title":"Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients","volume":"144","author":"Delong","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00044011-200626010-00001","article-title":"Cost effectiveness of levocetirizine in chronic idiopathic urticaria: a pooled analysis of two randomised controlled trials","volume":"26","author":"Kapp","year":"2006","journal-title":"Clin Drug Investig"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2133.1988.tb03246.x","article-title":"Urticaria: then and now","volume":"119","author":"Champion","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1398-9995.2009.02325.x","article-title":"Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper","volume":"65","author":"Church","year":"2010","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2009.11.047","article-title":"The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria","volume":"125","author":"Staevska","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB62|cit62","first-page":"223","article-title":"Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study","volume":"17","author":"Dubertret","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jaci.2008.12.008","article-title":"High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study","volume":"123","author":"Siebenhaar","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2133.2007.08060.x","article-title":"Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients","volume":"157","author":"Kameyoshi","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","article-title":"Randomized double-blind study of cyclosporin in chronic \u2018idiopathic\u2019 urticaria","volume":"143","author":"Grattan","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2006.04.078","article-title":"Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial","volume":"55","author":"Vena","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000320233","article-title":"Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria","volume":"154","author":"Metz","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaci.2010.05.047","article-title":"Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab","volume":"126","author":"Magerl","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2008.07.006","article-title":"Treatment of chronic autoimmune urticaria with omalizumab","volume":"122","author":"Kaplan","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1081-1206(10)60232-3","article-title":"Therapeutic alternatives for chronic urticaria: additional reports on omalizumab","volume":"101","author":"Spector","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)60644-8","article-title":"Effect of omalizumab on patients with chronic urticaria","volume":"99","author":"Spector","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/147323000903700422","article-title":"Treatment of chronic idiopathic urticaria with levamisole: a multicentre, randomized, double-blind, controlled trial","volume":"37","author":"Zhang","year":"2009","journal-title":"J Int Med Res"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1468-3083.2009.03289.x","article-title":"The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20\u2003mg","volume":"23","author":"Gim\u00e9nez-Arnau","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1398-9995.2008.01893.x","article-title":"Comparison of the efficacy of levocetirizine 5\u2003mg and desloratadine 5\u2003mg in chronic idiopathic urticaria patients","volume":"64","author":"Potter","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2340\/00015555-0434","article-title":"Treatment of chronic urticaria with narrowband ultraviolet B phototherapy: a randomized controlled trial","volume":"88","author":"Engin","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1468-3083.2007.02385.x","article-title":"Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study","volume":"22","author":"Grob","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1468-3083.2007.02511.x","article-title":"Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria","volume":"22","author":"Khalaf","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1398-9995.2007.01330.x","article-title":"Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study","volume":"62","author":"Gimenez-Arnau","year":"2007","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB79|cit79","first-page":"157","article-title":"The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria","volume":"79","author":"Spector","year":"2007","journal-title":"Cutis"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00128071-200708010-00005","article-title":"Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"8","author":"Ortonne","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB81|cit81","first-page":"649","article-title":"Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial","volume":"16","author":"Pons-Guiraud","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/0378-6323.26735","article-title":"Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine","volume":"72","author":"Godse","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-4632.2005.02609.x","article-title":"Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study","volume":"45","author":"Kapp","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2133.2005.07049.x","article-title":"Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study","volume":"154","author":"Nettis","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S1081-1206(10)61325-7","article-title":"Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study","volume":"94","author":"Kaplan","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaci.2004.06.018","article-title":"Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria","volume":"114","author":"Di Lorenzo","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1365-2222.2004.02019.x","article-title":"Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study","volume":"34","author":"Nettis","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/09546630310013450","article-title":"Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria","volume":"15","author":"Handa","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mjd.2003.143","article-title":"Efficacy and safety of desloratadine 5\u2003mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial","volume":"48","author":"Monroe","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1081-1206(10)62322-8","article-title":"Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children","volume":"87","author":"La Rosa","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000056337","article-title":"Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial","volume":"14","author":"Camarasa","year":"2001","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1365-4362.2001.00186.x","article-title":"Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study","volume":"40","author":"Ring","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1081-1206(10)62515-X","article-title":"Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria","volume":"84","author":"Nelson","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB94|cit94","first-page":"205","article-title":"Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group","volume":"10","author":"Leynadier","year":"2000","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0091-6749(99)70091-6","article-title":"A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria","volume":"104","author":"Finn","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1468-3083.1999.tb00802.x","article-title":"Efficacy and safety of mizolastine 10\u2003mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study","volume":"12","author":"Dubertret","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/106002809603001001","article-title":"Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria","volume":"30","author":"Breneman","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1398-9995.1996.tb00092.x","article-title":"Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria","volume":"51","author":"Brostoff","year":"1996","journal-title":"Allergy"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0190-9622(95)90233-3","article-title":"Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial","volume":"33","author":"Breneman","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1398-9995.2010.02496.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1398-9995.2008.01913.x","article-title":"How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life","volume":"64","author":"Grob","year":"2009","journal-title":"Allergy"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.2010.02496.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1398-9995.2010.02496.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T04:47:07Z","timestamp":1711946827000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.2010.02496.x"}},"subtitle":["Unmet clinical needs in chronic urticaria"],"short-title":[],"issued":{"date-parts":[[2010,11,17]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.2010.02496.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.720716979.793514407","asserted-by":"object"}]},"ISSN":["0105-4538"],"issn-type":[{"value":"0105-4538","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,17]]}}}